Key Trends Influencing the Growth of the Recombinant DNA Technology Market in 2025: Technological Advancements Driving Innovation In Recombinant DNA Technology Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Recombinant DNA Technology Market Through 2025?
There has been a substantial growth in the market size of recombinant DNA technology in the past few years. It is projected to increase from $858.94 billion in 2024 to $913.42 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The expansion during the historic period is due to factors like health care needs, biopharmaceutical industry progression, increased investments in research and development, and the dawn of personalized medicine.

What's the Projected Size of the Global Recombinant DNA Technology Market by 2029?
In the ensuing years, it is projected that the recombinant dna technology market size will significantly expand, reaching around $1299.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. This projected growth in the forecast period can be credited to the increasing incidence of chronic diseases, emergence of new biotech startups, elevation in biotech funding, globalization of biotech markets, as well as improved consumer acceptance and education. Major influences shaping the forecast period include strides in scientific and gene editing technologies, advances in cell and gene therapies, the progress of RNA therapeutics, medical applications in the treatment of rare diseases, and the incorporation of AI and data.

View the full report here:
https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Top Growth Drivers in the Recombinant DNA Technology Industry: What's Accelerating the Market?
The surge in chronic diseases is predicted to fuel the expansion of the recombinant DNA technology market. Chronic illnesses, characterized by conditions persisting for a year or more, requiring continuous medical attention, or limiting daily activities, or both, are a growing concern. The healthcare sector has been revolutionized by recombinant DNA technology, which manufactures biopharmaceutical proteins for pharmaceutical use and replaces faulty genes with healthy ones in an effort to cure diseases through gene therapy. For example, the World Health Organization, a Switzerland-based intergovernmental body, reported in February 2024 that by 2050, there would be over 35 million new cancer cases, indicating a 77% increase from the approximately 20 million cases anticipated in 2022. As a result, the rise in chronic diseases is stimulating the development of the recombinant DNA technology market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8233&type=smp

Which Emerging Trends Are Transforming the Recombinant DNA Technology Market in 2025?
Advancements in technology serve as a pivotal trend in the recombinant DNA technology market. Leading companies in this market are prioritizing innovative techniques to maintain their market dominance. For instance, in August 2022, the American biotech firm, Bluebird bio, Inc., unveiled ZYNTEGLO, a one-off gene therapy approved by the U.S. Food and Drug Administration (FDA). This treatment addresses beta-thalassemia by focusing on its genetic root cause offering the opportunity for patients to cease their routine red blood cell transfusions. This treatment utilizes an ex-vivo lentiviral vector for patient cell modification and is recognized as the debut FDA-endorsed gene therapy for the condition within the U.S. This significant breakthrough lessens the long-term demands of managing beta-thalassemia.

What Are the Main Segments in the Recombinant DNA Technology Market?
The recombinant dna technology market covered in this report is segmented -

1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell And Gene Therapy, Gene Editing
2) By Component Type: Expression System, Cloning Vector
3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types
4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types

Subsegments:
1) By Recombinant Protein Drugs: Hormones, Growth Factors
2) By Vaccines: Recombinant Viral Vaccines, Recombinant Bacterial Vaccines, Subunit Vaccines
3) By Genetically Modified Crops: Herbicide-Tolerant Crops, Insect-Resistant Crops, Nutritionally Enhanced Crop
4) By Expression Systems: Bacterial Expression Systems, Yeast Expression Systems, Mammalian Expression Systems
5) By Cell And Gene Therapy: Cell-Based Therapies, Gene Replacement Therapies, CAR T-Cell Therapies
6) By Gene Editing: CRISPR Or Cas9 Technologies, TALENs (Transcription Activator-Like Effector Nucleases), ZFNs (Zinc Finger Nucleases)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8233&type=smp

Which Top Companies are Driving Growth in the Recombinant DNA Technology Market?
Major companies operating in the recombinant DNA technology market are Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co. Inc., Biogen Inc., GlaxoSmithKline PLC, New England Biolabs Inc., Bayer CropScience, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., Moderna Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc., bluebird bio Inc., Illumina Inc., Qiagen N.V., Lonza Group AG, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Becton Dickinson and Company, Sartorius AG, Abcam PLC, Horizon Discovery Group PLC, Integrated DNA Technologies Inc., Twist Bioscience Corporation, Synthego Corporation, Codex DNA Inc., InvivoGen, Eurofins Scientific SE, Sarepta Therapeutics Inc., Sangamo Therapeutics Inc.

Which Regions Will Dominate the Recombinant DNA Technology Market Through 2029?
North America was the largest region in the recombinant DNA technology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant DNA technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8233

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.